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Abstract  
Introduction: there are indications that oxidized low density lipoprotein cholesterol (Ox-LDLC) may play an important role in cardiovascular 
disease (CVD) events. In most developing countries, the interplay between the different lipid fractions and cigarette smoking has not been studied. 
This study assessed the effect of cigarette smoking on the alterations in plasma lipid fractions and their associations with the gonadal hormone, 
testosterone (T). Methods: one hundred and sixty male participants, consisting of eighty smokers and eighty apparently healthy non-smokers 
were recruited. Anthropometric indices and biochemical parameters were determined using standard procedures. Results: significant increases 
were obtained in plasma total cholesterol (TC), triglyceride (TG), oxidized low density lipoprotein (Ox-LDLC) and Ox-LDLC/TT ratio (p. 
Conclusion: this study showed an inverse correlation between Ox-LDLC and testosterone as well as strong association between the number of 
tobacco and cigarettes usage per day. These changes in part, could be major causes of premature CVD and decreased fertility in young adults. 
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Introduction 
 
The health consequences of smoking cigarettes and other tobacco 
related products are well known. They are important major health 
hazard in the development of atherosclerosis and cardiovascular 
disease (CVD) [1]. The connections between cigarette smoking and 
CVD have been addressed by several investigators [2-4]. In the 
INTERHEART study, Frick et al [5] indicated an overall population 
attributable risk of about 38% between smoking and myocardial 
infarction. Tobacco smoke in general contains numerous compounds 
majorly among which are nicotine, carbon monoxide and various 
carcinogens [3]. These compounds do have effects on the metabolic 
and biological processes of the body including the modification of 
lipoproteins, especially the LDLC [6], the oxidized form of which has 
been shown to accumulate excessively in arterial walls, leading to 
increased peroxidation both in vitro and in vivo [7]. Recent 
experimental and clinical data also suggest that exposure to 
cigarette and other tobacco related smoke increases oxidative 
stress, thereby compounding the potential mechanism(s) for 
initiating cardiovascular dysfunction through the activities of nicotine 
in cigarettes which enhances fat oxidation [8]. Experimental and 
clinical data [9] indicates that nicotine in cigarette smoke changes 
lipoproteins, particularly LDLC into the oxidized form(ox-LDLC) thus 
quickening its uptake by macrophages, thereby leading to the 
progression of atherosclerosis [3].There is also a growing interest 
following several studies on the link between cigarette smoking and 
low testosterone levels in men in relation to the development of 
coronary heart disease[10,11]. Overall, males have been shown to 
have a higher risk of CVD in comparison to premenopausal women, 
with the incidence in women increasing after menopause and a 
concomitant decrease in the gender difference in mortality and 
morbidity [12, 13]. In a developing country like Nigeria, where there 
is not much enlightenment on the implications and adverse effects 
of smoking cigarette and other tobacco related products are not 
known, a sizeable number of the male population are involved in 
this habit. The aim of this study therefore, was to ascertain the 
relationship between smoking, the different fractions of lipids and 
gonadal hormone. The results we believe will highlight the 
relationship between these parameters in our targeted subjects.  
  
  
Methods 
 
One hundred and sixty apparently healthy male participants 
consisting of eighty smokers (44.4±1.7 years) and eighty non-
smokers (35.1±1.0 years) were recruited for this study. The 
smokers were recruited from motor parks and military barracks; 
areas where the habit is a common occurrence. The smokers 
consumed at least 4 sticks of cigarette daily. Demographic data such 
as lifestyle pattern, smoking habit, alcohol use, socioeconomic 
status and medical history were obtained from each participant 
based on questionnaire adapted from the work of Ebesunun et al, 
[14]. The controls were men who had never been involved in 
cigarette smoking at any stage of their life. Informed consent was 
also obtained from participants before commencement of study.  
  
Anthropometric measurements  
  
The weight of each participant in kilogram was taken using a Seca 
adult weighing scale. The height in centimeter was taken using a 
fixed meter rule without foot wear. The body mass index (BMI) in 
kg/m2 of each subject was calculated using weight/height2  
 
 
Sample collection  
  
Blood samples were collected from all subjects after an overnight 
fast (10-12 hours) into EDTA bottles. The blood samples were 
immediately placed on ice bag and plasma was separated within 
short time of collection. The plasma samples were thereafter stored 
in at -20° C until analyzed for biochemical parameters.  
  
Biochemical analysis  
  
Total cholesterol was determined using the method of Alain et al, 
[15] while the triglyceride was estimated by the enzymatic method 
of David and Buccolo [16]. LDLC and VLDLC were precipitated out 
by the addition of phosphotungstic acid in the presence of 
magnesium ions. After centrifugation, the cholesterol concentration 
in the supernatant representing the HDLC fraction was determined 
with the method used for total cholesterol estimation. The LDLC was 
calculated using the formula of Friedwald et al, [17]. Ox-LDLC was 
analyzd using an Enzyme Immunoaborbent Assay (EIA) method 
based on the principle of competitive binding between Ox-LDLC in 
the test sample and oxidized LDL-HRP conjugate for a constant 
amount of rabbit anti-oxidized LDLC. Testosterone analysis was 
based on the principle of competitive binding between T in the test 
sample and testosterone-HRP conjugate for a constant amount of 
rabbit anti-testosterone. Accuracy and precision of biochemical tests 
were monitored by the inclusion of commercial quality control 
samples with each batch of assay.  
  
Statistical analysis  
  
All results were subjected to statistical analysis using SPSS version 
14 software (SPSS Inc. Chicago, Illinois) for windows. Student t-test 
was used for comparison of variables. Post Hoc analysis was also 
carried out. Pearson correlation coefficient was used to assess the 
relationship between variables. The results were expressed in mean 
± S.E and the level of significance was accepted at p < 0.05.  
  
  
Results 
 
Results are presented in tables 1-3 below: Table 1 shows 
biophysical and biochemical parameters in smokers and non-
smokers. Smokers were older than non-smokers (p 
  
Table 2 shows the biophysical and biochemical parameters in 
smokers based on the duration (years) of cigarettes smoked. These 
were made up of two groups; group 1 consisted of smokers that 
have been smoking between 5 to 13 years, while group 2 consisted 
of those that have smoked between 14 to 22 years. Smokers in 
group 1 were young than smokers in group2 (p0.001) were not 
significantly different in the two groups. Comparison of parameters 
between military men and motor park vendors did not show any 
significant changes between the groups.  
  
Table 3 shows Pearson correlation (r) coefficient, this indicated that 
plasma TC was significantly correlated with HDLC (r=0.958,pFigure 
1 shows a graph of Ox-LDLC in smokers and non-smokers. The 
smokers showed significantly higher value of plasma Ox-LDLC. 
Figure 2 shows a graph of testosterone in smokers and non-
smokers. The smoker had a lower mean plasma testosterone.  
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Discussion 
 
A significant and clinically relevant finding in this study was that the 
plasma level of Ox-LDLC was significantly increased in smokers and 
the level of significance was associated with increasing number of 
cigarettes and tobacco usage per day. Furthermore, this study 
showed a low level of mean total testosterone in smokers although 
this increase was not statistically significant, but was inversely 
correlated with Ox-LDLC. Thus suggesting that as the Ox-LDLC 
increases plasma T decreases. The possible reason for this is that 
after receptor -mediated endocytosis of LDLC, cholesterol removed 
from LDL is used for diverse metabolic processes required for 
healthy functioning cells including the synthesis of testosterone. 
However, modified/oxidized LDL is not recognised by the receptor 
and instead is taken up by scavenger receptor macrophages. The 
uptake of Ox-LDLC does not lead to its degradation. Instead it 
accumulates in the macrophages as cholesteryl esters, therefore 
foam cells and these amass in the sub-endothelial space, 
contributing to atherosclerotic plaques [18]. We could not 
demonstrate whether the low mean plasma testosterone proceeds 
or were a direct effect of smoking. More pronounced responses 
regarding hormones are found in most cases with heavy smokers. 
Since most of the subjects are light smokers, this could be the 
cause of the variance found between this study and those of others 
[19-21].  
  
An epidemiology study in the North Eastern Nigeria [22] indicated 
that smoking is common among the low income earners. This was 
also revealed from the questionnaire on socioeconomic status used 
in this study. The reason for this is not known, but we speculate 
that since the majority of our subjects are motor park 
vendors/military men who had little or no education, and therefore 
do not have any idea on the pathophysiology of smoking. The 
possible mechanism linking low testosterone and elevated Ox-LDLC 
in smokers is plausible. Smoking is known to be a modifier of the 
male reproductive hormones, T [23,24]. Its association with 
impaired lipid profile could be a major factor that promotes diseases 
like atherosclerosis and CVD especially in heavy smokers. Ox-LDLC 
is increasingly formed in smokers possibly, as a result of the 
reaction between the lipid fractions in LDL particles and the reactive 
oxygen species generated by the toxicants in cigarette and tobacco 
smoke [9, 25]. Cigarette and tobacco smoke are established source 
of free radicals generation [2] which increases oxidative stress and 
other associated complications like endothelium damage and lipid 
oxidation. A high level of Ox-LDLC in the body therefore, is 
deleterious. According to previous studies [26,27], Ox-LDLC is also a 
major risk factor associated with atherosclerotic plaque formation. 
Significant and higher levels of plasma total cholesterol, triglyceride, 
and LDLC were obtained in this study. Several suggestions have 
been put forward; among which are that the effect of nicotine in the 
cigarette and tobacco smoke causes lipolysis through stimulation of 
catecholamine, and therefore increasing cholesterol, TG, free fatty 
acids and LDLC [20, 2]. Changes in lipid profile in smokers and the 
risk of increased tobacco related diseases have also been indicated 
to be dose dependent [28] and may as well be related to the 
duration of the habit. The role of dietary differences between 
smokers and non-smokers as well as free radical-mediated oxidative 
stress as a pivotal step for the development of atherosclerosis could 
also be relevant.  
  
This study also demonstrated that smokers have significantly lower 
levels of plasma HDLC than the controls subjects. The reason for 
this low level is not clear; it may possibly be a pointer to a 
significant cardiovascular risk. Available evidence indicates that for 
every milligram decrease in plasma HDLC due to cigarette smoking 
or any other factors, there is a 2.5% chance of increased premature 
CVD development [29].  
  
  
Conclusion 
 
The evidence from this study suggests a strong relationship 
between increased plasma Ox-LDLC and number of 
tobacco/cigarettes usage per day. The inverse correlation between 
testosterone and Ox-LDLC obtained in this study indicates that 
increases in Ox-LDLC can lead to reduce plasma testosterone in 
smokers. These changes in part, could lead to decreased fertility 
and premature CVD events in young adults.  
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Table 1: biophysical and biochemical parameters of smokers and non-smokers(Mean+ S.E.M) 
Variables Smokers n=80 Non-smokers n=80 t-value p-value 
BMI (kg/m2)        21.3±3.6 22.4±2.8 .86 NS 
TC(mg/dl) 211.7±1.3 174.4±2.6 -12.7 p<0.001 
TG (mg/d) 129.9±1.2 115.2±2.4 -5.6 p<0.001 
HDLC(mg/dl) 40.2±0.8 47.1±0.7 6.8 p<0.001 
LDLC(mg/dl) 143.7±1.8 102.6±2.8 -12.3 p<0.001 
Ox-LDL (ng/dl)    65.4±0.7 44.4±0.4 -19.8 p<0.001 
TT (ng/dl)           4.7±0.1            . 4.9±0.1 .73 NS 
LDLC/Ox-LDLC 13.9±0.1 9.1±0.1 .106 NS 
Ox-LDLC/TT 13.9±0.1 9.1±0.1 27.1 p<0.001 
Age (years)             44.4±1.7 35.1±1.0 -11.2 p<0.001 
BMI=Body Mass Index. TC=Total Cholesterol. TG=Triglyceride.  
TT =TotalTestosterone   HDLC=High Density Lipoprotein Cholesterol.  
LDLC= Low DensityLipoprotein Cholesterol.        Ox-LDLC=Oxidized LDLC.   
p= Level of significance.  NS= not significant.     
Table 2: biophysical and biochemical parameters of smokers based on the duration (in years) of cigarette smoked.  (Mean 
+ S.E.M) 
Variables 
GP1=5-
13years(n=35) 
  
GP2=14-22 years 
(n=45) 
t- value p-value 
BMI (kg/m2)        22.3±3.6 21.7±2.8 10.2 NS 
TC (mg/dl)           206.4±1.5 214.3±2.6 -9.7 p<0.001 
TG (mg/dl)         126.1±1.2 132.8±2.4 -8.6 p<0.001 
HDLC (mg/dl)         39.8±0.8 36.4±0.7 11.8 p<0.001 
LDLC (mg/dl)         132.7±1.8 157.2±2.8 -18.3 p<0.001 
Ox-LDLC(ng/dl)     55.6±0.7 67.4±0.4 -19.8 p<0.001 
TT (ng/dl)         4.5±0.1 4.7±0.1 5.3 NS 
LDLC/Ox-LDLC  2.4±0.1 2.3±0.1 9.6 NS 
Ox-LDLC/TT 12.9±0.1 14.3±0.1 -24.1 p<0.001 
Age (years)       32.8±1.7 39.1±1.0 -16.8 p<0.001 
BMI=Body Mass Index. TC=Total Cholesterol. TG=Triglyceride.  
TT =TotalTestosterone   HDLC=High Density Lipoprotein Cholesterol.  
LDLC= Low DensityLipoprotein Cholesterol.   Ox-LDLC=Oxidized LDLC.   
GP= group.p = Level of significance.  NS= not significant.     
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Figure 1: oxidised-low density lipoprotein cholesterol in smokers and non smokers  
 
 
 
 
 
 
 
 
 
 
Table 3: Pearson correlation coefficeint of  biochemical  parameters in smokers 
Variables TC (mg/dl) HDLC (mg/dl) LDLC(mg/dl) Ox-LDLC(ng/dl) TT (ng/dl) 
TC (mg/dl)   .958** .989** .974** .632* 
HDLC (mg/dl)         958**   -.975** .955** .577* 
LDLC (mg/dl)           .989** -.957**   .981** .615* 
Ox-LDLC (ng/dl)       .974 .955** .981**   -.649* 
TT (ng/dl)                 .632* .577* .615* -.649*   
Pearson Correlation coefficient significant at **p<0.01 
 * P<0.05 
TT =TotalTestosterone   HDLC=High Density Lipoprotein Cholesterol.  
LDLC= Low DensityLipoprotein Cholesterol.     Ox-LDLC=Oxidized LDLC 
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Figure 2: total testosterone in smokers and non smokers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
